Prospect

Elliott Management is asking FERC to let it purchase up to one-fifth of the common stock in a Texas utility.

Today on TAP: The UAW is asking the Big Three automakers to raise wages by the same percentage that their CEOs’ pay has risen.

Look past the headline numbers and the story begins to emerge. Whether Biden’s strategy can outlast this rough patch is another question.

Thanks to an ill-considered move by Joe Biden and the DNC, several fringe Democrats will be on the ballot in the nation’s first primary, and the president will be on the sidelines.

A surge of federal funding from the American Rescue Plan has helped cities develop pilot guaranteed income programs. Will they last?

Today on TAP: Exhibit A is the case of the EpiPen. It should cost a few dollars rather than the $600 or more charged by monopolist Viatris.

Extreme inequality is bad for billionaires and ordinary citizens alike.

The Department of Labor plans to reverse the neoliberal-era gutting of a law that stopped contractors from bidding down wages in federal procurement.

Bidenomics has begun to de-financialize the economy.

As Brian Fallon leaves Demand Justice, one of several groups highlighting the urgency of the courts, the movement he helped lead has made real gains.

Today on TAP: The sly myopia of David Brooks

In a newly unsealed deposition, a former Express Scripts executive (unintentionally) reveals how hard his colleagues were undermining his ‘mission’ to cut drug prices.

The wave of professionals who are joining unions has now reached the ranks of physicians.

The credit card industry is attempting to whip up right-wing hysterics to fight a bipartisan financial reform.

Let’s make this trade.

Today on TAP: He’s too deluded to know he lost! Coups that fail don’t count! And other cornucopias of crap!

How orphan drugs became big business for Big Pharma

Jack Smith is doing the attorney general’s job for him, 28 months after it should have been done.

The trucking company’s demise reads like a history of modern capitalism.

An independent report casts doubt on the credibility of a major gas certification company.